Suanfarma Biotech
Suanfarma Biotech is a Spain-headquartered, ARCHIMED-backed manufacturer of active pharmaceutical ingredients (APIs) and CDMO services, combining fermentation and chemical synthesis across GMP sites in Portugal and Italy to serve 400+ pharmaceutical and animal-health customers in 75+ countries.
- Company typePrivate
- Founded1993
- HeadquartersAlcobendas, Spain
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Suanfarma Biotech does
Suanfarma Biotech, founded in 1993 and headquartered in Alcobendas (Madrid), Spain, is a privately held manufacturer of active pharmaceutical ingredients (APIs) and contract development and manufacturing (CDMO) services. It operates as a portfolio company of the private equity firm ARCHIMED. Suanfarma produces both human APIs (spanning antibiotics, cardiovascular, and oncology molecules such as Ribociclib Succinate and Bisoprolol) and veterinary APIs (including Albendazole, Tiamulin, and Fluralaner), alongside chemical intermediates, and serves pharmaceutical and animal-health customers globally. Following the December 2025 divestiture of its nutraceutical ingredients subsidiary SuanNutra, the company is focused on its API and CDMO core.
The company runs an integrated fermentation and chemical synthesis platform across two GMP-certified European manufacturing sites: Cipan in Castanheira do Ribatejo, Portugal (described as one of the largest fully GMP-compliant fermentation facilities in Europe) and Rovereto in Italy (acquired from Sandoz/Novartis in 2019). Technical capabilities include industrial-scale fermentation using bacteria, yeast, and fungi, flow chemistry for safer and more sustainable reactions, digital twin process simulation (claimed to cut tech transfer timelines by 20-30%), IoT-and-AI predictive maintenance, and OEB 4 high-potency containment for oncology APIs. The R&D function develops 2-3 new products per year.
Suanfarma generates revenue through three streams: direct API sales (proprietary and generic APIs to pharma companies), CDMO services (process development, tech transfer, scale-up, and GMP manufacturing), and co-development plus regulatory consulting (dossier preparation and registration support). Distribution is handled through a global network of 10 area offices serving 400+ active customers in more than 70 countries, complemented by selective partner distribution such as UQUIFA for Albendazole. Pricing is quote-based and tailored to volume and regulatory market, with regulatory filings (DMF, CEP, CTD) bundled into the offering across 70+ jurisdictions.
Suanfarma Biotech firmographics
Firmographics- Name
- Suanfarma Biotech
- Legal name
- SUANFARMA
- Website
- http://www.suanfarma.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Suanfarma Biotech is a Spain-headquartered, ARCHIMED-backed manufacturer of active pharmaceutical ingredients (APIs) and CDMO services, combining fermentation and chemical synthesis across GMP sites in Portugal and Italy to serve 400+ pharmaceutical and animal-health customers in 75+ countries.
- Ownership category
- akta.pro rank
Suanfarma Biotech industry classification
Industry- Product category
- Active Pharmaceutical Ingredient (API) Manufacturing and CDMO Services
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
- akta.pro secondary industries
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)
Keywords
Where Suanfarma Biotech is headquartered
LocationHeadquarters
- HQ city
- Alcobendas
- HQ country
- Spain
- HQ region
- Europe
Offices10 records
Markets served
Suanfarma Biotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Infrastructure, Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Revenue model
- Active Pharmaceutical Ingredients (API) Sales: Manufacturing and sale of high-quality active pharmaceutical ingredients including human APIs, veterinary APIs, and intermediate products. Revenue is generated through direct supply of proprietary and generic APIs to pharmaceutical companies globally.
- CDMO (Contract Development and Manufacturing Organization) Services: End-to-end contract manufacturing and development services including process development, technology transfer, scale-up, and GMP manufacturing for pharmaceutical and biotech companies. Services span from early-stage feasibility through commercial-scale production.
- Co-Development and Regulatory Consulting: Collaborative product development, regulatory strategy, and dossier preparation services for pharmaceutical and biotech partners. Revenue generated through project-based consulting engagements and co-development partnerships.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Suanfarma Biotech product offering
Product offeringCore offering
Suanfarma Biotech develops, manufactures, and globally distributes Active Pharmaceutical Ingredients (human APIs, veterinary APIs, and intermediate products) and provides integrated Contract Development and Manufacturing Organization (CDMO) services combining fermentation and chemical synthesis. Manufacturing is performed at two European GMP-compliant facilities (Cipan in Portugal, Rovereto in Italy) and supplied to pharmaceutical and biotech customers in 75+ countries via direct enterprise sales backed by 10 commercial offices.
Product overview
Suanfarma is a pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs) with a diversified portfolio spanning Human APIs (antibiotics, cardiovascular, oncology), Veterinary APIs (antiparasitics, antibiotics), and Intermediate Products. The company operates through two integrated divisions: API Distribution (marketing and distributing proprietary and third-party APIs globally) and CDMO Services (contract manufacturing combining fermentation and chemical synthesis). Manufacturing is conducted at two European GMP-compliant facilities: Cipan in Portugal and Rovereto in Italy. The CDMO platform offers integrated services including process development, technology transfer, scale-up, and commercial manufacturing, with advanced capabilities in flow chemistry and digital twin technology for process optimization.
Differentiator
Problem solved
Functional benefit
Brands
- Suanfarma CDMO: Unified brand for Suanfarma's Contract Development and Manufacturing Organization services, encompassing fermentation and chemical synthesis capabilities at Cipan and Rovereto facilities.
- Suanfarma CDMO
Products and services
- Human APIs Active pharmaceutical ingredients for human medicine applications, including antibiotics, cardiovascular treatments (e.g., Bisoprolol), and oncology drugs. Supplied to pharmaceutical and biotech companies globally with full regulatory documentation (DMF, CTD, CEP).
- Veterinary APIs Active pharmaceutical ingredients for animal health applications, including antiparasitics (Albendazole, Oxibendazole, Tiamulin, Fluralaner) and antibiotics for livestock and companion animals. Suanfarma was the first European manufacturer to fully supply Tiamulin with CEP and DMF approval for Europe and the USA.
- Intermediate Products Pharmaceutical intermediate compounds used as building blocks in the synthesis of active pharmaceutical ingredients, supplied globally to API manufacturers.
- Ribociclib Succinate API Selective CDK4/6 inhibitor API used in targeted anticancer therapy for HR-positive, HER2-negative advanced and metastatic breast cancer. Offered in Polymorphic Form A with purity greater than 98%, produced in OEB 4 GMP-compliant facilities with full DMF and CTD regulatory documentation.
- Suanfarma CDMO Services Contract Development and Manufacturing Organization services offering integrated end-to-end solutions for API development and manufacturing, combining fermentation and chemical synthesis capabilities. Spans process development, technology transfer, scale-up, and commercial GMP manufacturing for pharmaceutical and biotech partners.
- Fermentation Services Industrial-scale bioconversion through fermentation processes that produce complex molecular intermediates from renewable raw materials using bacteria, yeast, or fungi. Includes lab-to-industrial-scale production of APIs and intermediates among the largest fully GMP-compliant fermentation operations in Europe.
- Chemical Synthesis Services Precision chemical synthesis capabilities for API production, including complex reactions, hydrogenations, distillations, crystallizations, and drying processes, integrated with fermentation in modular hybrid production lines for efficient campaign transitions.
- Regulatory and Technical Support Services Comprehensive technical and regulatory package including DMF and CTD documentation, polymorphic form confirmation, impurity characterization, CEP support, and compliance assistance for global market registration across 70+ regulatory markets.
- Co-Development Services Collaborative product development, regulatory strategy, and dossier preparation services for pharmaceutical and biotech partners, leveraging Suanfarma's fermentation and chemical synthesis platform and global regulatory expertise.
Quantifiable outcome
- 20-30% reduction in technology transfer timelines through Digital Twin technology
- +2 more outcomes
Companies that use Suanfarma Biotech
Customer profileSegments3 records
Ideal customer profiles2 records
Suanfarma Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Suanfarma Biotech partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Fundación Lucha contra las InfeccionescoreStrategic collaboration between Suanfarma and the Fight Infections Foundation (Fundación Lucha contra las Infecciones), a non-profit entity with over 30 years of scientific leadership in infectious disease research, prevention, and treatment. The partnership supports advanced research in critical areas for global health including HIV, COVID-19, and neglected diseases, aligning with Suanfarma's API development and supply activities.
- la Caixa FoundationminorSuanfarma joined the Child Vaccination Alliance, an initiative established by la Caixa Foundation in collaboration with Gavi, the Vaccine Alliance, and with scientific support from ISGlobal. The alliance provides Spanish companies with an opportunity to contribute to a cooperative project combating child mortality in developing countries. Funds are directed toward vaccine distribution in Mozambique and Ethiopia, targeting pneumonia prevention.
- Gavi, the Vaccine AllianceminorSuanfarma participates in the Child Vaccination Alliance alongside Gavi, contributing to vaccination programs for children under 5 in 73 of the world's poorest countries. la Caixa Foundation and the Bill and Melinda Gates Foundation match donations up to 2 million euros.
- Fundación ArraigominorSuanfarma founded and serves as patron of Fundación Arraigo, established to help migrants in Spain by providing basic education and resources to facilitate labor integration. The foundation has supported 1,950 people, 560 families, and delivered 750 diplomas across multiple training and employment projects.
- UQUIFAcoreSuanfarma distributes Albendazole manufactured by UQUIFA at its plant in Mexico. This partnership enables Suanfarma to offer antiparasitic APIs under high quality and accessibility standards, combining UQUIFA's manufacturing capabilities with Suanfarma's global distribution network.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
Suanfarma Biotech competitors and assessment
Company assessmentBroad incumbents
- Fareva: French privately-held pharmaceutical manufacturer covering APIs, finished dosage forms and cosmetics/industrial manufacturing across Europe. Broad European incumbent with overlapping CDMO/API capabilities.
- Cambrex: US-headquartered CDMO owned by Permira, focused on small-molecule API development and manufacturing. Established global CDMO incumbent overlapping with Suanfarma's small-molecule API offerings.
- Recipharm: Large Swedish CDMO (PE-owned by EQT) covering APIs, finished dosage forms and biologics across many sites. Broader CDMO incumbent that competes with Suanfarma for complex API outsourcing contracts.
- WuXi STA (WuXi AppTec): Chinese CDMO covering small-molecule API and integrated CMC services globally. Representative of the Asian low-cost CDMO competitors against which Suanfarma's European dual-sourcing positioning is increasingly sold.
Direct peers
- Siegfried Holding: Swiss-listed CDMO offering integrated API manufacturing including controlled substances and fermentation-derived molecules, with dual-site European production. Closely comparable in scope, regulatory depth and CDMO platform strategy.
- Carbogen Amcis: Swiss-headquartered CDMO specializing in API development, including fermentation-derived and highly potent compounds, with Indian manufacturing via the Dishman site. Comparable in fermentation + high-potency API niche.
- AGC Pharma Chemicals: CDMO arm of AGC offering small-molecule API development and manufacturing including fermentation and chemical synthesis capabilities. Competes directly with Suanfarma CDMO for similar innovator and generic API projects.
- EuroAPI: European API manufacturer spun out of Sanofi in 2022, focused on small-molecule APIs across multiple therapeutic areas with global customer reach. Directly comparable in product portfolio and European industrial API footprint.
- Hovione: Portugal-headquartered CDMO combining chemistry, fermentation and particle engineering for small-molecule APIs. Closest geographic and capability analogue to Suanfarma's Cipan/Portuguese footprint and dual fermentation-chemical synthesis model.
- Olon Group: Italian CDMO and one of the largest global manufacturers of generic APIs with fermentation and chemical synthesis capabilities across multiple sites. Direct European-headquartered peer with overlapping capabilities to Cipan and Rovereto.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Suanfarma Biotech social profiles
Digital presenceSuanfarma Biotech compliance and trust
Trust signalCompliance3 records
Suanfarma Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Suanfarma Biotech leadership team
Management profileNumber of profiles
Profiles7 records
Suanfarma Biotech subsidiaries and ownership
Company hierarchySubsidiaries4 records
Suanfarma Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Suanfarma Biotech M&A and investment
M&A and investmentM&A1 record
Investments4 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Suanfarma Biotech
What does Suanfarma Biotech do?
Suanfarma Biotech develops, manufactures, and globally distributes Active Pharmaceutical Ingredients (human APIs, veterinary APIs, and intermediate products) and provides integrated Contract Development and Manufacturing Organization (CDMO) services combining fermentation and chemical synthesis. Manufacturing is performed at two European GMP-compliant facilities (Cipan in Portugal, Rovereto in Italy) and supplied to pharmaceutical and biotech customers in 75+ countries via direct enterprise sales backed by 10 commercial offices.
Is Suanfarma Biotech a public or private company?
Suanfarma Biotech is a private company. It is classified as private equity controlled and is currently operating.
When was Suanfarma Biotech founded?
Suanfarma Biotech was founded in 1993. It employs 101 to 250 people.
Where is Suanfarma Biotech based?
Suanfarma Biotech is headquartered in Alcobendas, Spain, in the Europe region.
How does Suanfarma Biotech make money?
Three revenue lines are on record. Active Pharmaceutical Ingredients (API) Sales are the primary driver. The others are CDMO (Contract Development and Manufacturing Organization) Services and co-Development and Regulatory Consulting.
Who are Suanfarma Biotech's main competitors?
Broad incumbents on record are Fareva, Cambrex, Recipharm and WuXi STA (WuXi AppTec). Direct peers are Siegfried Holding, Carbogen Amcis, AGC Pharma Chemicals, EuroAPI, Hovione and Olon Group.
Does Suanfarma Biotech have an API?
No public API is recorded for Suanfarma Biotech.
What industry is Suanfarma Biotech in?
Suanfarma Biotech's product category is Active Pharmaceutical Ingredient (API) Manufacturing and CDMO Services. Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO). Its NAICS code is 325411 and its SIC code is 2833.